VIEIRA ROBERTO WANDENKOLK (President, Oncology) sold 93.2% of their position (58.33K shares) of CORCEPT THERAPEUTICS INC on the open market

Open‑market sale worth $6.46M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 7 sales

VIEIRA ROBERTO WANDENKOLK

Filed: 9/4/2026ACC: 0001193125-26-382456

InsiderVIEIRA ROBERTO WANDENKOLKCIK 2150104

→

IssuerCORCEPT THERAPEUTICS INCCIK 1088856

Officer· President, Oncology

Since Sep 2026

-58.16K

Net shares

Net seller

$6.47M

Total sold

Open market trades

0B · 7S

Total transactions

58.61K acquired · 116.77K disposed

Non-Derivative Transactions11

Common Stock

Direct

A · Award

+138.00

Price / share

$113.38

Trade value

$15.65K

% of position

3.4%

9/1/2026

4.07K→4.21K

Common Stock

Direct

A · Award

+138.00

Price / share

—

Trade value

—

% of position

3.3%

9/1/2026

4.21K→4.34K

Common Stock

Direct

F · Tax Withholding

−102.00

Price / share

$113.38

Trade value

$11.56K

% of position

2.3%

9/2/2026

4.34K→4.24K

Common Stock

Direct

M · Option Exercise

+58.33K

Price / share

$21.63

Trade value

$1.26M

% of position

1375.1%

9/2/2026

4.24K→62.58K

Common Stock

Direct

S · Sale

−23.60K

Price / share

$109.35

Trade value

$2.58M

% of position

37.7%

9/2/2026

62.58K→38.98K

Common Stock

Direct

S · Sale

−23.77K

Price / share

$110.70

Trade value

$2.63M

% of position

61.0%

9/2/2026

38.98K→15.21K

Common Stock

Direct

S · Sale

−1.54K

Price / share

$111.37

Trade value

$171.18K

% of position

10.1%

9/2/2026

15.21K→13.67K

Common Stock

Direct

S · Sale

−974.00

Price / share

$112.40

Trade value

$109.47K

% of position

7.1%

9/2/2026

13.67K→12.69K

Common Stock

Direct

S · Sale

−1.61K

Price / share

$113.72

Trade value

$182.63K

% of position

12.7%

9/2/2026

12.69K→11.09K

Common Stock

Direct

S · Sale

−5.62K

Price / share

$114.58

Trade value

$644.04K

% of position

50.7%

9/2/2026

11.09K→5.47K

Common Stock

Direct

S · Sale

−1.23K

Price / share

$115.44

Trade value

$141.41K

% of position

22.4%

9/2/2026

5.47K→4.24K

Total

Net shares

+174.00

Net value

-$5.19M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Stock Direct	9/1/2026	A · Award	+138.00	$113.38	$15.65K	3.4%	4.07K	4.21K
Common Stock Direct	9/1/2026	A · Award	+138.00	—	—	3.3%	4.21K	4.34K
Common Stock Direct	9/2/2026	F · Tax Withholding	−102.00	$113.38	$11.56K	2.3%	4.34K	4.24K
Common Stock Direct	9/2/2026	M · Option Exercise	+58.33K	$21.63	$1.26M	1375.1%	4.24K	62.58K
Common Stock Direct	9/2/2026	S · Sale	−23.60K	$109.35	$2.58M	37.7%	62.58K	38.98K
Common Stock Direct	9/2/2026	S · Sale	−23.77K	$110.70	$2.63M	61.0%	38.98K	15.21K
Common Stock Direct	9/2/2026	S · Sale	−1.54K	$111.37	$171.18K	10.1%	15.21K	13.67K
Common Stock Direct	9/2/2026	S · Sale	−974.00	$112.40	$109.47K	7.1%	13.67K	12.69K
Common Stock Direct	9/2/2026	S · Sale	−1.61K	$113.72	$182.63K	12.7%	12.69K	11.09K
Common Stock Direct	9/2/2026	S · Sale	−5.62K	$114.58	$644.04K	50.7%	11.09K	5.47K
Common Stock Direct	9/2/2026	S · Sale	−1.23K	$115.44	$141.41K	22.4%	5.47K	4.24K
Total			+174.00		-$5.19M

Derivative Transactions1

Stock option (right to buy)

Direct

M · Option Exercise

Converts to

Common Stock

58.33K shares

−58.33K

Strike price

21.63

Held after

141.67K

Exercisable

—

9/2/2026

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable	Held After
Stock option (right to buy) Direct	Common Stock58.33K shares	9/2/2026	M · Option Exercise	−58.33K	21.63	—	141.67K